دورية أكاديمية
National Policy Influences of Contraceptive Prevalence and Method Mix Strategy: A Longitudinal Analysis of 59 Low- and Middle-Income Countries, 2010-2021.
| العنوان: | National Policy Influences of Contraceptive Prevalence and Method Mix Strategy: A Longitudinal Analysis of 59 Low- and Middle-Income Countries, 2010-2021. |
|---|---|
| المؤلفون: | Cohen MA; Chemonics International, New York, NY, USA. mcohen@chemonics.com., Gold S; Chemonics International, Washington, DC, USA., Ostrega A; Chemonics International, Washington, DC, USA., Zingbagba M; Chemonics International, Kumasi, Ghana. |
| المصدر: | Global health, science and practice [Glob Health Sci Pract] 2024 Apr 29; Vol. 12 (2). Date of Electronic Publication: 2024 Apr 29 (Print Publication: 2024). |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| اللغة: | English |
| بيانات الدورية: | Publisher: U.S. Agency for International Development and Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs Country of Publication: United States NLM ID: 101624414 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2169-575X (Electronic) Linking ISSN: 2169575X NLM ISO Abbreviation: Glob Health Sci Pract Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Baltimore, MD : U.S. Agency for International Development and Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs, 2013- |
| مواضيع طبية MeSH: | Developing Countries* , Contraception*/statistics & numerical data , Family Planning Services* , Family Planning Policy*, Humans ; Longitudinal Studies ; Female ; Contraception Behavior/statistics & numerical data ; Prevalence ; Private Sector ; Contraceptive Agents |
| مستخلص: | Understanding the impact of family planning policy and actions is essential for building effective strategies to increase contraceptive use. This study identifies policies that correlate with modern contraceptive prevalence rate (mCPR) and private-sector contraceptive method mix strategies (the number of contraceptive methods offered in the private sector) in low-income and middle-income countries. While education, contraceptive choices, and economic growth are known determinants of contraceptive prevalence, many national policies intended to increase contraceptive prevalence in the short term to medium term have ambiguous evidence that they indeed do so. By developing beta and Poisson regression models using 12 years of reported Contraceptive Security Indicators Survey data (2010-2021) from 59 countries, this study investigated the effect of 20 independent variables on mCPR or method mix strategies. Furthermore, to help interpret the potential consequences of economic status, separate models segmented by gross national income (low, low-middle, and upper-middle) were assessed. Of 20 independent variables, 10 are implicated with mCPR and 6 with a method mix strategy. Of these, increasing the share of domestic financing (versus donor funding) for contraceptives had the broadest and strongest contribution. mCPR is also predicted by the existence of national insurance systems that cover contraceptive costs, contraceptive security committees, family planning logistics management information systems, and, inversely, by client fees. A comprehensive private-sector method mix strategy-which itself influences mCPR-is also driven by these, as well as the inclusion of more contraceptives on the national essential medicines list. These findings have implications for countries seeking to expand access to and use of contraceptives through policy initiatives. (© Cohen et al.) |
| References: | Stud Fam Plann. 2014 Jun;45(2):151-69. (PMID: 24931073) Health Aff (Millwood). 2009 May-Jun;28(3):853-63. (PMID: 19414898) Soc Sci Med. 2020 Dec;267:112496. (PMID: 31515082) Vaccine. 2017 Apr 19;35(17):2233-2242. (PMID: 28364937) Trop Med Int Health. 2010 Jan;15(1):94-7. (PMID: 19917038) Glob Health Sci Pract. 2013 Jul 26;1(2):203-12. (PMID: 25276533) Health Econ. 2007 Mar;16(3):257-73. (PMID: 17001737) BMJ Open. 2020 Sep 25;10(9):e041103. (PMID: 32978208) Int Perspect Sex Reprod Health. 2017 Jun 1;43(2):41-50. (PMID: 29261505) Stud Fam Plann. 2016 Dec;47(4):341-356. (PMID: 27859370) J Glob Health. 2022 Oct 14;12:04086. (PMID: 36227754) Stud Fam Plann. 1988 Nov-Dec;19(6 Pt 1):313-34. (PMID: 3068840) BMC Public Health. 2013;13 Suppl 3:S3. (PMID: 24564484) Lancet. 2012 Jul 14;380(9837):111-25. (PMID: 22784531) Health Econ Rev. 2015 Feb 07;5:2. (PMID: 25853000) BMC Public Health. 2009 Dec 14;9:462. (PMID: 20003411) Lancet. 2022 Jul 23;400(10348):295-327. (PMID: 35871816) Lancet. 2018 Mar 3;391(10123):870-882. (PMID: 29217374) Afr J Reprod Health. 2019 Sep;23(3):96-105. (PMID: 31782635) |
| المشرفين على المادة: | 0 (Contraceptive Agents) |
| تواريخ الأحداث: | Date Created: 20240411 Date Completed: 20240429 Latest Revision: 20240729 |
| رمز التحديث: | 20240730 |
| مُعرف محوري في PubMed: | PMC11057802 |
| DOI: | 10.9745/GHSP-D-23-00352 |
| PMID: | 38604782 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2169-575X |
|---|---|
| DOI: | 10.9745/GHSP-D-23-00352 |